S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.0135 SEK 7.14% Market Closed
Market Cap: 11.3m SEK

Intrinsic Value

S2M's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one S2M stock under the Base Case scenario is 0.0301 SEK. Compared to the current market price of 0.0135 SEK, S2Medical AB (publ) is Undervalued by 55%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

S2M Intrinsic Value
0.0301 SEK
Undervaluation 55%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
S2Medical AB (publ)

Valuation History Unavailable

Historical valuation for S2M cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare S2M to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about S2M?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about S2Medical AB (publ)
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
S2Medical AB (publ)

Current Assets 5.7m
Cash & Short-Term Investments 1m
Receivables 2.3m
Other Current Assets 2.3m
Non-Current Assets 12.4m
PP&E 402k
Intangibles 12m
Efficiency

Free Cash Flow Analysis
S2Medical AB (publ)

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
S2Medical AB (publ)

Revenue
14.9m SEK
Cost of Revenue
-766k SEK
Gross Profit
14.1m SEK
Operating Expenses
-8.3m SEK
Operating Income
5.8m SEK
Other Expenses
-20k SEK
Net Income
5.8m SEK
Fundamental Scores

S2M Profitability Score
Profitability Due Diligence

S2Medical AB (publ)'s profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional ROE
Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
42/100
Profitability
Score

S2Medical AB (publ)'s profitability score is 42/100. The higher the profitability score, the more profitable the company is.

S2M Solvency Score
Solvency Due Diligence

S2Medical AB (publ)'s solvency score is 62/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
Long-Term Solvency
Short-Term Solvency
62/100
Solvency
Score

S2Medical AB (publ)'s solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

S2M Price Targets Summary
S2Medical AB (publ)

There are no price targets for S2M.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

S2Medical AB (publ)
does not pay dividends
Shareholder Yield

Current shareholder yield for S2M is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

S2M Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one S2M stock?

The intrinsic value of one S2M stock under the Base Case scenario is 0.0301 SEK.

Is S2M stock undervalued or overvalued?

Compared to the current market price of 0.0135 SEK, S2Medical AB (publ) is Undervalued by 55%.

Back to Top